Paper19251722
Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.
Wang Y and 8 others. Cardiovasc Res, 2009. Cited by 140 papers, by iCite.
Cite this record
ConductScience Library. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Papers, record 19251722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19251722
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AMP-Activated Protein Kinases | Major topic |
| Berberine | Major topic |
| Endothelial Cells | Major topic |
| Hyperglycemia | Major topic |
| Nitric Oxide Synthase Type III | Major topic |
| Animals | |
| Aorta | |
| Apoptosis | |
| Cell Adhesion | |
| Cell Line | |
| Enzyme Activation | |
| Humans | |
| Male | |
| Monocytes | |
| NF-kappa B | |
| Nitric Oxide | |
| Rats | |
| Rats, Sprague-Dawley | |
| Reactive Oxygen Species | |
| Signal Transduction | |
| Vasodilation |
Source PubMed
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41901214 | Self-Assembled Rg3/Naringenin Nanoparticles for Targeted Brain Delivery: A Promising Therapeutic Approach for Early Alzheimer's Disease. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901214 | PubMed |
| 41767379 | Mechanisms and applications of natural plant ingredients in modulating amino acid metabolism for the improvement of diabetic retinopathy: a review. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41767379 | PubMed |
| 41596399 | Berberine: A Negentropic Modulator for Multi-System Coordination. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596399 | PubMed |
| 41394126 | Targeting L-arginine/NO/cGMP/KATP pathway by phytochemicals: therapeutic applications and clinical perspectives. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41394126 | PubMed |
| 41243097 | Berberine ameliorates high-fat diet-induced metabolic disorders through promoting gut Akkermansia and modulating bile acid metabolism. | Chin Med | 2025 | https://conductscience.org/library/papers/41243097 | PubMed |
| 41089338 | Berberine's impact on health: Comprehensive biological, pharmacological, and nutritional perspectives. | Metabol Open | 2025 | https://conductscience.org/library/papers/41089338 | PubMed |
| 40502549 | A Review of the Mechanisms of Astragaloside IV and Berberine in Vascular Dysfunction Associated with Obesity and Diabetes. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40502549 | PubMed |
| 40192797 | Levo-corydalmine derived from Rhizoma Corydalis suppresses Ox-LDL-induced endothelial cell activation and improves vasodilatation by regulating the DDIT3-eNOS pathway. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40192797 | PubMed |
| 38957396 | Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38957396 | PubMed |
| 38275993 | A Mechanistic Review on How Berberine Use Combats Diabetes and Related Complications: Molecular, Cellular, and Metabolic Effects. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/38275993 | PubMed |
| 38034996 | Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38034996 | PubMed |
| 37902881 | Bioactive molecules from terrestrial and seafood resources in hypertension treatment: focus on molecular mechanisms and targeted therapies. | Nat Prod Bioprospect | 2023 | https://conductscience.org/library/papers/37902881 | PubMed |
| 37780378 | Berberine protects hepatocyte from hypoxia/reoxygenation-induced injury through inhibiting circDNTTIP2. | PeerJ | 2023 | https://conductscience.org/library/papers/37780378 | PubMed |
| 37759984 | AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37759984 | PubMed |
| 37298967 | A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention. | Molecules | 2023 | https://conductscience.org/library/papers/37298967 | PubMed |
| 37049878 | Thermodynamic Parameters of Berberine with Kolliphor Mixtures Adsorption and Micellization. | Molecules | 2023 | https://conductscience.org/library/papers/37049878 | PubMed |
| 36094643 | Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts. | Invest Ophthalmol Vis Sci | 2022 | https://conductscience.org/library/papers/36094643 | PubMed |
| 35950214 | Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice. | Mol Ther Nucleic Acids | 2022 | https://conductscience.org/library/papers/35950214 | PubMed |
| 35879716 | Berberine ameliorates mesenteric vascular dysfunction by modulating perivascular adipose tissue in diet-induced obese in rats. | BMC Complement Med Ther | 2022 | https://conductscience.org/library/papers/35879716 | PubMed |
| 35784732 | Berberine Suppresses Lung Metastasis of Cancer via Inhibiting Endothelial Transforming Growth Factor Beta Receptor 1. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35784732 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19251722
GET https://conductscience.org/api/papers/v1/19251722/cited_by?page=2